Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Next batch of compounds sent for biological testing Feb 2018 #26

Closed
edwintse opened this issue Feb 26, 2018 · 13 comments
Closed

Next batch of compounds sent for biological testing Feb 2018 #26

edwintse opened this issue Feb 26, 2018 · 13 comments

Comments

@edwintse
Copy link
Contributor

edwintse commented Feb 26, 2018

The first batch of compounds for year (shown below) have now been shipped to Dundee for screening against P. falciparum.

UPDATE 24/3/18 RESULTS ARE IN AND ARE POSTED BELOW.

dundee compounds 260218

MMV Number SMILES InChI InChI Key
MMV1579336 FC(F)OC(C=C1)=CC=C1C2=NN=C3C=NC=C(OCC(C(O)=O)C4=CC=CC=C4)N32 InChI=1S/C21H16F2N4O4/c22-21(23)31-15-8-6-14(7-9-15)19-26-25-17-10-24-11-18(27(17)19)30-12-16(20(28)29)13-4-2-1-3-5-13/h1-11,16,21H,12H2,(H,28,29) FICNFVPYGUTYFV-UHFFFAOYSA-N
MMV669784 FC(F)OC(C=C1)=CC=C1C2=NN=C3C=NC=C(OC4=CC=C(Cl)C=C4)N32 InChI=1S/C18H11ClF2N4O2/c19-12-3-7-13(8-4-12)26-16-10-22-9-15-23-24-17(25(15)16)11-1-5-14(6-2-11)27-18(20)21/h1-10,18H WXNPYOXFQUYIOI-UHFFFAOYSA-N
MMV1579337 FC1=CC(CCOC2=CN=CC3=NN=C(N4CCOCC4)N32)=CC=C1F InChI=1S/C17H17F2N5O2/c18-13-2-1-12(9-14(13)19)3-6-26-16-11-20-10-15-21-22-17(24(15)16)23-4-7-25-8-5-23/h1-2,9-11H,3-8H2 BBKXHWRASNHAOR-UHFFFAOYSA-N
MMV1579338 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=CC(C(N(C)C)=O)=C4)N32)=CC=C1F InChI=1S/C22H19F2N5O2/c1-28(2)22(30)16-5-3-4-15(11-16)21-27-26-19-12-25-13-20(29(19)21)31-9-8-14-6-7-17(23)18(24)10-14/h3-7,10-13H,8-9H2,1-2H3 PWLRVFJPMJABKE-UHFFFAOYSA-N
MMV1579339 FC(C(F)=C1)=CC=C1CCOC2=CN=CC3=NN=C(OCCC4=CC(F)=C(F)C=C4)N32 InChI=1S/C21H16F4N4O2/c22-15-3-1-13(9-17(15)24)5-7-30-20-12-26-11-19-27-28-21(29(19)20)31-8-6-14-2-4-16(23)18(25)10-14/h1-4,9-12H,5-8H2 PCFGQRSVXZZXPK-UHFFFAOYSA-N
MMV1579340 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(N5CCOCC5)C=C4)N32)=CC=C1F InChI=1S/C23H21F2N5O2/c24-19-6-1-16(13-20(19)25)7-10-32-22-15-26-14-21-27-28-23(30(21)22)17-2-4-18(5-3-17)29-8-11-31-12-9-29/h1-6,13-15H,7-12H2 YZCOBAJWPPWSFU-UHFFFAOYSA-N
MMV1579341 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C5C(NC=C5)=C4)N32)=CC=C1F InChI=1S/C21H15F2N5O/c22-16-4-1-13(9-17(16)23)6-8-29-20-12-24-11-19-26-27-21(28(19)20)15-3-2-14-5-7-25-18(14)10-15/h1-5,7,9-12,25H,6,8H2 VHFREJHLTSVZGA-UHFFFAOYSA-N
MMV1579342 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(N)C=C4)N32)=CC=C1F InChI=1S/C19H15F2N5O/c20-15-6-1-12(9-16(15)21)7-8-27-18-11-23-10-17-24-25-19(26(17)18)13-2-4-14(22)5-3-13/h1-6,9-11H,7-8,22H2 PGJZGRJIPPSPJV-UHFFFAOYSA-N
MMV1579343 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(N5CCCCC5)C=C4)N32)=CC=C1F InChI=1S/C24H23F2N5O/c25-20-9-4-17(14-21(20)26)10-13-32-23-16-27-15-22-28-29-24(31(22)23)18-5-7-19(8-6-18)30-11-2-1-3-12-30/h4-9,14-16H,1-3,10-13H2 IBAQRAIPMINXCX-UHFFFAOYSA-N
MMV1579344 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(N5CCCC5)C=C4)N32)=CC=C1F InChI=1S/C23H21F2N5O/c24-19-8-3-16(13-20(19)25)9-12-31-22-15-26-14-21-27-28-23(30(21)22)17-4-6-18(7-5-17)29-10-1-2-11-29/h3-8,13-15H,1-2,9-12H2 MKNMPQGWOUWNLB-UHFFFAOYSA-N
MMV1579345 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(NC(C)=O)C=C4)N32)=CC=C1F InChI=1S/C21H17F2N5O2/c1-13(29)25-16-5-3-15(4-6-16)21-27-26-19-11-24-12-20(28(19)21)30-9-8-14-2-7-17(22)18(23)10-14/h2-7,10-12H,8-9H2,1H3,(H,25,29) PLEIRUOVWBUIKA-UHFFFAOYSA-N
MMV1579346 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=CC(NC(C)=O)=C4)N32)=CC=C1F InChI=1S/C21H17F2N5O2/c1-13(29)25-16-4-2-3-15(10-16)21-27-26-19-11-24-12-20(28(19)21)30-8-7-14-5-6-17(22)18(23)9-14/h2-6,9-12H,7-8H2,1H3,(H,25,29) DFKJCMXUKUTORD-UHFFFAOYSA-N
MMV1579347 FC1=CC(CCOC2=CN=CC3=NN=C(N4CCC(F)(F)CC4)N32)=CC=C1F InChI=1S/C18H17F4N5O/c19-13-2-1-12(9-14(13)20)3-8-28-16-11-23-10-15-24-25-17(27(15)16)26-6-4-18(21,22)5-7-26/h1-2,9-11H,3-8H2 QEKAFCQAHVHCHN-UHFFFAOYSA-N
MMV1579348 FC1=CC(CCOC2=CN=CC3=NN=C(N4CCC(F)CC4)N32)=CC=C1F InChI=1S/C18H18F3N5O/c19-13-3-6-25(7-4-13)18-24-23-16-10-22-11-17(26(16)18)27-8-5-12-1-2-14(20)15(21)9-12/h1-2,9-11,13H,3-8H2 XGYZBGPCRAEWAT-UHFFFAOYSA-N
MMV1579349 FC1=CC(CCOC2=CN=CC3=NN=C(N4CCC(C(F)(F)F)CC4)N32)=CC=C1F InChI=1S/C19H18F5N5O/c20-14-2-1-12(9-15(14)21)5-8-30-17-11-25-10-16-26-27-18(29(16)17)28-6-3-13(4-7-28)19(22,23)24/h1-2,9-11,13H,3-8H2 VSNCNIYPDHLNGV-UHFFFAOYSA-N
MMV1579350 FC1=C(F)C=C(CCOC2=CN=CC3=NN=C(N4CCN(C)CC4)N32)C=C1 InChI=1S/C18H20F2N6O/c1-24-5-7-25(8-6-24)18-23-22-16-11-21-12-17(26(16)18)27-9-4-13-2-3-14(19)15(20)10-13/h2-3,10-12H,4-9H2,1H3 PXDXCQZMCIITIC-UHFFFAOYSA-N
MMV1579351 FC1=CC(CCOC2=CN=CC3=NN=C(C4=CC=C(N(C)C)C=C4)N32)=CC=C1F InChI=1S/C21H19F2N5O/c1-27(2)16-6-4-15(5-7-16)21-26-25-19-12-24-13-20(28(19)21)29-10-9-14-3-8-17(22)18(23)11-14/h3-8,11-13H,9-10H2,1-2H3 DWKVYGNKXDMKJI-UHFFFAOYSA-N
MMV1557865 FC(F)OC(C=C1)=CC=C1C2=NN=C3C=NC=C(OCC(CO)C4=CC=C(O)C=C4)N32 InChI=1S/C21H18F2N4O4/c22-21(23)31-17-7-3-14(4-8-17)20-26-25-18-9-24-10-19(27(18)20)30-12-15(11-28)13-1-5-16(29)6-2-13/h1-10,15,21,28-29H,11-12H2 BCDILCAJSSYWKE-UHFFFAOYSA-N

Dundee Compounds 260218.zip

@david1597
Copy link
Contributor

david1597 commented Mar 23, 2018

Results are in. Data shown is the average of two runs. Data has been added to the Master List, and to the 'Biological Data currently not incorporated into the main Wiki sections wiki'

dundee results 260218

Dundee Results 260218.zip

@david1597
Copy link
Contributor

david1597 commented Mar 24, 2018

@cdsouthan
Copy link
Member

OSM-S-525 potency is certainly encouraging but a re-syn and a replicated re-test at two assay centres would be in order (and can go in the paper as a diligent reproducability test). If this goes well we might even convince Tocris to put it up as a purchasable reference cpd

@mattodd
Copy link
Member

mattodd commented Apr 4, 2018

Hi @david1597 @edwintse does one of you have the above data (in whatever form we get them from ScienceCloud) posted somewhere on the ELN? We ought to have the primary data there, with the summary data here and on the wiki. Also, the image on the "Not yet added to the wiki" page also needs some link back to an ELN. We will need links of this kind to primary data for the paper.

Also going to ping Neil Norcross for any comment on these data.

@mattodd mattodd reopened this Apr 4, 2018
@david1597
Copy link
Contributor

Primary data from ScienceCloud is now on my ELN. This ELN link has also been added to the Not Yet On The Wiki page.

Also, pdf of the two runs are below as direct links:
Dundee_Feb18_ScienceCloud_MMV11_0040_18ANDM-017_25uM.pdf
Dundee_Feb18_ScienceCloud_MMV11_0040_18ANDM-018_25uM.pdf.

@mattodd
Copy link
Member

mattodd commented Apr 9, 2018

Neil Norcross wrote by email today, after seeing the latest data. He recommended a focus on OSM-S-525:

"I would resynthesize and retest this compound in the first instance, to ensure this is a true result.

If it is, you might want to consider the 4 compounds below, to follow up on MMV1579341.

variants of 525

Reducing the number of aromatic rings and logP would be a priority.

Do you have any mammalian (counter screen) cell data? Mouse hepatocyte, solubility and PAMPA data would also be very useful, if possible. (MHT - tox was included in the original screen? We're getting rat hep, sol soon)

Key questions:

How important is the NH of the indole?

Is moving the NH2 from the para (MMV1579342) to the meta position better tolerated, in line with the indole NH?

Does the 5 membered ring (mr) of the indole need to be aromatic or can the double bond be reduced (to the aliphatic 5 mr)?

Can the logP be reduced further by introducing polar groups into the 5 membered ring (amide or sulphonamide) and are they tolerated?

Also, how metabolically stable is the phenol ether (O-dealkylation)?" (MHT - this was assessed some time ago OpenSourceMalaria/OSM_To_Do_List#334)

Strings:
1
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(N)=CC=C4)N32)=C1
InChI=1S/C19H15F2N5O/c20-15-5-4-12(8-16(15)21)6-7-27-18-11-23-10-17-24-25-19(26(17)18)13-2-1-3-14(22)9-13/h1-5,8-11H,6-7,22H2
CQZOPOXKTPBXOH-UHFFFAOYSA-N

2
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(NCC5)=C5C=C4)N32)=C1
InChI=1S/C21H17F2N5O/c22-16-4-1-13(9-17(16)23)6-8-29-20-12-24-11-19-26-27-21(28(19)20)15-3-2-14-5-7-25-18(14)10-15/h1-4,9-12,25H,5-8H2
FNBXJZBLBXZUFU-UHFFFAOYSA-N

3
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(NC(C5)=O)=C5C=C4)N32)=C1
InChI=1S/C21H15F2N5O2/c22-15-4-1-12(7-16(15)23)5-6-30-20-11-24-10-18-26-27-21(28(18)20)14-3-2-13-9-19(29)25-17(13)8-14/h1-4,7-8,10-11H,5-6,9H2,(H,25,29)
PUDALCIATSASSD-UHFFFAOYSA-N

4
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(NS(C5)(=O)=O)=C5C=C4)N32)=C1
InChI=1S/C20H15F2N5O3S/c21-15-4-1-12(7-16(15)22)5-6-30-19-10-23-9-18-24-25-20(27(18)19)13-2-3-14-11-31(28,29)26-17(14)8-13/h1-4,7-10,26H,5-6,11H2
JPYPGECXOMLEIE-UHFFFAOYSA-N

Variants of 525.zip

@MFernflower
Copy link
Contributor

MFernflower commented Apr 9, 2018

Regarding the sulfur compound this seems to be the only precursor that can be bought: (I think its worth saving up money to get norcross compound 4 made by a custom synth house like epichem)
enamine

I believe compound 1 has already been made @maratsydney ??

I also wonder if a close relative of the norcross sulfonamide can easily be made (provided it's stable):

idea21

@cdsouthan
Copy link
Member

cdsouthan commented Apr 9, 2018

Convergent thinking with Norcross on resyn/retest (but I was a week ahead :)

capture

@cdsouthan
Copy link
Member

cdsouthan commented Apr 9, 2018

While we are pushing for final data for the paper it would be good maybe for @david1597 & @mattodd to have a technical discussion with Dundee and MMV about a re-assay campaign for the front runners/ sub 100 nM hits and pivotal activity cliffs. Its great to see the raw data from Dundee (and full credit for their turnaround) but its clear from the charts that these are scoping IC50s with big error ranges (even missing the crucial points on the inflections in some cases). As @david1597 indicated elsewhere repeats are coming in with ranges of ~2-fold on a good day. Consequently, we are ending up with jellyfish SAR (i.e. wobbling values difficult to nail down). For comparison, data from @MedChemProf PfATP4_mutantsummary_MCPHS.pdf are more towards the tighter side we should aim for (e.g. +/- ~ 20- 30% ) although much depends on the extent of technical replicates and the data processing package used (e.g. EnzFitter or whatever)

@MFernflower
Copy link
Contributor

What do you mean by jellyfish SAR - we have a bunch of diffrent stuff that works but dont know why? @cdsouthan

@mattodd
Copy link
Member

mattodd commented Apr 11, 2018

Further thoughts just in from Neil Norcross by email:

A few more points to consider, if the ‘meta aniline’ is tolerated, you could replace the Cl for a F at the para position, which could work in a number of different ways: reduce logP, form an intra molecular H-bond to improve permeability, pull electron density away from the NH2, reducing nucleophilicity but also increasing H-bond potential of an NH (one H bond would be tied up with the F atom), this could reduce the reactivity of the aniline to possible glucoronidation also, so mouse hepatocyte data will be key here. In addition, you would need to get any aniline of interest tested for AMES, sooner rather than later. Also, changing the electronics of the ring can have a huge impact on whether a compound is AMES positive or negative.

If the aniline at the meta position is key for activity and/or selectivity, you could always put a nitrogen atom at the para position (instead of the chlorine), giving you the amino pyridine, which could be very useful, if tolerated. The amino pyridine will modulate the pKa of the aniline (can increase pKa by 2 log units), so if aniline has a pKaH of ca. 5, the amino pyridine could have a pKaH of ca. 7. (The pKa of the amino pyridine can also be impacted by the electronics of the adjacent ring). If the aminopyridine is protonated at physiological pH, this may also improve your solubility and potentially, modulate in vivo properties such as volume of distribution and half-life. Also, compared to the aniline, the amino pyridine moiety can mitigate AMES and/or glucoronidation.

variants of 525 part 2

I would be cautious about adding the acid groups (meta or para), which is likely to kill your permeability (in vitro and in vivo) and may also impact on getting into red blood cells, for antimalarial screening. I appreciate that you can use acid bioiosteres as a replacement but it’s certainly something to be wary of.

Variants of 525 Part 2.zip

Strings
5
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(N)=C(F)C=C4)N32)=C1
InChI=1S/C19H14F3N5O/c20-13-3-1-11(7-15(13)22)5-6-28-18-10-24-9-17-25-26-19(27(17)18)12-2-4-14(21)16(23)8-12/h1-4,7-10H,5-6,23H2
VZPHEOZUAXBEIA-UHFFFAOYSA-N

6
FC1=C(F)C=CC(CCOC2=CN=CC3=NN=C(C4=CC(N)=NC=C4)N32)=C1
InChI=1S/C18H14F2N6O/c19-13-2-1-11(7-14(13)20)4-6-27-17-10-22-9-16-24-25-18(26(16)17)12-3-5-23-15(21)8-12/h1-3,5,7-10H,4,6H2,(H2,21,23)
FKGHXQVSFJVZKU-UHFFFAOYSA-N

@MFernflower
Copy link
Contributor

MFernflower commented Apr 11, 2018

Reading Neil's musings gave me rather crazy but possibly effective ideas:

@mattodd @mcoster @drc007 What do you guys think?

(I cannot seem to find S-triazine boronic acids anywhere so this might be a tricky one to make real)
Where R = NH2, H, or Me
dddddd

The boronic acid for this can be grabbed off of matrix - http://www.matrixscientific.com/boronic-acids/068426.html

5ue

@drc007
Copy link

drc007 commented Apr 11, 2018

Is it possible to merge threads?

#31

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Projects
None yet
Development

No branches or pull requests

6 participants